![Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors]()
Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factorsDe Sousa, Sunita M C; Baranoff, John; Rushworth, R Louise; Butler, Jessica; Sorbello, Jane; Vorster, Juanita; Thompson, Tanya; McCormack, Ann I; Inder, Warrick J; Torpy, David J · The Journal of Clinical Endocrinology & Metabolism · 2019